| Abstract
| - The synthesis and structure−activity relationship of a series of 5,6,7-trisubstituted 4-aminopyrido[2,3-d]pyrimidines as novel nonnucleoside adenosine kinase inhibitors is described.A variety of alkyl, aryl, and heteroaryl substituents were found to be tolerated at the C5, C6,and C7 positions of the pyridopyrimidine core. These studies have led to the identification ofanalogues that are potent inhibitors of adenosine kinase with in vivo analgesic activity.
|
